The Effect of Cataract Extraction on the Contractility of Ciliary Muscle

Sponsor
Samsung Medical Center (Other)
Overall Status
Unknown status
CT.gov ID
NCT00624039
Collaborator
(none)
15
1
1
22
0.7

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate the changes in the pilocarpine-induced ciliary body movement before and after cataract extraction in order to determine the effect of lens sclerosis on the ciliary muscle contractility.

Condition or Disease Intervention/Treatment Phase
  • Other: UBM with pilocarpine in presbyopia
N/A

Detailed Description

The functional changes in the ciliary body in presbyopia are not only important in a study of the mechanism for presbyopia but are also a key to various procedures or devices used to restore accommodation. Therefore, it is becoming increasingly important to quantify the in vivo accommodative changes in the aging ciliary muscle with and without a lens. We are going to evaluate the changes in the pilocarpine-induced contractility of the ciliary muscle in eyes with presbyopia before and after cataract extraction using ultrasound biomicroscopy (UBM).UBM will be performed with and without instilling 2 % pilocarpine, as well as before and 2 months after cataract extraction. Images of the ciliary body will be compared visually using Adobe Photoshop 7.0.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
The Effect of Cataract Extraction on the Contractility of Ciliary Muscle
Study Start Date :
May 1, 2006
Anticipated Primary Completion Date :
Mar 1, 2008
Anticipated Study Completion Date :
Mar 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Other: 1

ultrasound biomicrocopic examinations and pilocarpine instillation

Other: UBM with pilocarpine in presbyopia
ultrasound biomicroscopic examination in both eyes 30 minutes after one drop of 2% pilocarpine hydrochloride (OcucarpineĀ®, Samil Pharm., Seoul, Korea) instillation before and two months after cataract surgery
Other Names:
  • UBM with pilocarpine
  • Outcome Measures

    Primary Outcome Measures

    1. ultrasound biomicroscopic findings (ciliary body axial length) [2 months before and after surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    55 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Age : same or more than 55 years

    • Patients with senile cataract who are going to get cataract surgery

    Exclusion Criteria:
    • Age : less than 55 years

    • Previous ocular disease other than cataract.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Samsung Medical Center Seoul Korea, Republic of 135-710

    Sponsors and Collaborators

    • Samsung Medical Center

    Investigators

    • Study Director: Changwon Kee, M.D., Department of Ophthalmology, Samsung Medical Center, Ilwon-dong, Kangnam-gu, Seoul, 135-710, Republic of Korea. E-mail: ckee@skku.edu

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00624039
    Other Study ID Numbers:
    • CB2006
    First Posted:
    Feb 26, 2008
    Last Update Posted:
    Feb 26, 2008
    Last Verified:
    May 1, 2006
    Keywords provided by , ,
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 26, 2008